Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Feasibility Analysis of LCD-SLA 3D Printing Technology for Overall Surgical Planning of Liver Malignant Tumors [NA]
This completed clinical trial assessed the feasibility of LCD-SLA 3D printing to assist in overall surgical planning for liver malignant tum…
-
CLINICAL_TRIALS other · 2024-12-18Clinical Trial Update: SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma. [Phase 2, Phase 3]
A Phase 2/3 study is evaluating SBRT with camrelizumab and apatinib as conversion therapy for unresectable hepatocellular carcinoma; the tri…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating ZG005 plus Bevacizumab versus Sintilimab plus Bevacizumab in advanced hepatocellular carcinoma is currently recruit…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating the use of radiotherapy in combination with immunotherapy to downstage advanced hepatocellular c…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC [Phase 1, Phase 2]
Phase 1/2 study evaluating PM8002 in combination with PM1009 as first-line therapy for hepatocellular carcinoma. The trial status is not yet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: LEOPARD Prospective Validation Cohort 1
This clinical trial update describes the LEOPARD prospective validation cohort 1 by Assistance Publique - Hôpitaux de Paris and lists condit…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms [NA]
This entry notes the completion of a clinical trial evaluating a comprehensive electronic cancer support system for managing cancer-related …
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery [Phase 2]
Phase 2 trial examining hepatic arterial infusion of floxuridine and dexamethasone with bevacizumab in patients with unresectable primary li…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy [Phase 4]
A Phase 4 trial evaluating response to immunotherapy in patients with advanced hepatocellular carcinoma and chronic hepatitis C virus infect…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases [Phase 1]
Phase 1 study assessing safety, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of RO7119929 (TLR7 agonist) in partici…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors [Phase 2]
This clinical trials update describes a multicenter, open-label Phase IIa study to evaluate the efficacy and safety of B1962 injections in a…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 clinical trial evaluating perioperative pembrolizumab plus lenvatinib for resectable hepatocellular carcinoma is currently recruitin…
-
CLINICAL_TRIALS other · 2024-12-06Clinical Trial Update: SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE [Phase 2]
Phase 2 clinical trial evaluating stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma patients with partial response to trans…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques
Completed clinical trial evaluating a triple recipient strategy using split, domino, and auxiliary techniques for hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development
A recruiting clinical trial aims to characterize immune genotypes and antibody profiles to discover diagnostic biomarkers for liver cancer d…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China
An observational clinical trial evaluating SIR-Spheres therapy for hepatocellular carcinoma in China, currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: An Artificial Intelligence System for ROSE of EUS-FNA Sample: a Prospective, Multicenter, Diagnostic Study.
This clinical trial update describes a prospective multicenter study evaluating an AI-assisted ROSE system for EUS-FNA samples to diagnose m…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation [NA]
A clinical trial is evaluating an immunohistochemical algorithm for diagnosing and classifying hepatocellular carcinoma with mutations in TE…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion
This completed clinical trial studied radiation toxicity in the liver using MRI-based perfusion to evaluate effects in liver cancer.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis [Phase 2]
Phase 2 trial comparing sorafenib plus hepatic arterial infusion versus sorafenib alone in hepatocellular carcinoma with major portal vein t…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Study on the Efficacy and Safety of Transarterial Chemoembolization Combined With Targeted Immunotherapy in Patients With Unresectable Hepatocellular Carcinoma
A clinical trial evaluating transarterial chemoembolization combined with targeted immunotherapy for unresectable hepatocellular carcinoma, …
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma [Phase 2]
Completed Phase 2 trial evaluating camrelizumab combined with apatinib as perioperative treatment for resectable hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma [NA]
A clinical trial is currently recruiting to evaluate the combination of dTACE-HAIC with bevacizumab and atezolizumab for advanced hepatocell…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma [NA]
Ongoing clinical trial comparing TACE–lenvatinib with TACE–lenvatinib–ablation for intermediate recurrent hepatocellular carcinoma is curren…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC [NA]
A clinical trial evaluating donafenib as adjuvant therapy after microwave ablation for recurrent hepatocellular carcinoma is currently recru…